Pharmacokinetics and Pharmacodynamics of Sibrafiban (Ro 48-3657), an Orally Active IIb/IIIa Antagonist, Administered Alone or in Combination with Heparin, Aspirin, and Recombinant Tissue-Type Plasminogen Activator in Beagles
1998 ◽
Vol 32
(3)
◽
pp. 397-405
◽
1999 ◽
Vol 82
(S 01)
◽
pp. 121-123
◽
1998 ◽
Vol 19
(1)
◽
pp. 31-38
◽
1996 ◽
Vol 27
(1)
◽
pp. 105-112
◽
1988 ◽
Vol 60
(02)
◽
pp. 255-261
◽
1992 ◽
Vol 68
(06)
◽
pp. 672-677
◽
1990 ◽
Vol 63
(02)
◽
pp. 241-245
◽
1989 ◽
Vol 62
(02)
◽
pp. 699-703
◽
1989 ◽
Vol 61
(03)
◽
pp. 497-501
◽